Kodiak Sciences (KOD) Current Assets (2017 - 2026)
Kodiak Sciences' (KOD) quarterly Current Assets came in at $175.3 million in Q1 2026, up 22.83% YoY from $142.7 million in Q1 2025, and down 18.41% on a QoQ basis from $214.8 million in Q4 2025.
Analysis
Kodiak Sciences (KOD) Current Assets (2017 - 2026) Analysis & Trends
Kodiak Sciences (KOD) has 10 years of Current Assets data on file, last reported at $175.3 million in Q1 2026.
- Quarterly Current Assets rose 22.83% year-over-year to $175.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $175.3 million (up 22.83% YoY) and the FY2025 annual result came in at $214.8 million, up 24.94% from the prior year.
- Current Assets eased to $175.3 million in Q1 2026, from $214.8 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $682.2 million in Q1 2022 to a low of $75.7 million in Q3 2025.
- A 5-year average of $314.3 million and a median of $251.5 million in 2024 frame the typical range for Current Assets.
- The widest YoY moves for Current Assets: up 24.94% in 2025, down 62.6% in 2025.
- Tracing KOD's Current Assets over 5 years: stood at $486.0 million in 2022, then tumbled by 40.47% to $289.3 million in 2023, then sank by 40.57% to $171.9 million in 2024, then grew by 24.94% to $214.8 million in 2025, then retreated by 18.41% to $175.3 million in 2026.
- The last three Current Assets figures came in at $175.3 million (Q1 2026), $214.8 million (Q4 2025), and $75.7 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 5.82 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.03 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 7.22 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 4.62 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.76 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Kodiak Sciences | 2.21 Bn | 2.21 Bn | - | 131.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 131.36 Mn |
| Mar 31, 2026 | 175.26 Mn |
| Dec 31, 2025 | 214.82 Mn |
| Sep 30, 2025 | 75.73 Mn |
| Jun 30, 2025 | 107.92 Mn |
| Mar 31, 2025 | 142.69 Mn |
| Dec 31, 2024 | 171.94 Mn |
| Sep 30, 2024 | 202.49 Mn |
| Jun 30, 2024 | 224.63 Mn |
| Mar 31, 2024 | 251.51 Mn |
| Dec 31, 2023 | 289.31 Mn |
| Sep 30, 2023 | 350.93 Mn |
| Jun 30, 2023 | 386.96 Mn |
| Mar 31, 2023 | 431.12 Mn |
| Dec 31, 2022 | 486.01 Mn |
| Sep 30, 2022 | 544.66 Mn |
| Jun 30, 2022 | 604.37 Mn |
| Mar 31, 2022 | 682.19 Mn |
| Dec 31, 2021 | 734.81 Mn |
| Sep 30, 2021 | 805.51 Mn |